Innoviva, Inc. (Nasdaq:INVA)
Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.
1350 Old Bayshore Highway
Suite 400
Burlingame, California 94010
112
$14.88
14.72 - 15.26
10.64 - 16.87
746.1K
12.35M (02/15/24)
19.78%
$964.85M
$324.26M
N/A
N/A
Director Odysseas Demosthenes Kostas MD |
Independent Director Jules Haimovitz |
Independent Director Sarah J Schlesinger MD |
Independent Director Mark A Dipaolo |
Independent Director Sapna R Srivastava PhD |
Date | Form | Event |
---|---|---|
22 Aug, 2024 | 4 | |
31 Jul, 2024 | 10-Q | |
31 Jul, 2024 | 8-K | |
20 Jun, 2024 | 8-K | |
20 Jun, 2024 | 4 | |
20 Jun, 2024 | 4 | |
20 Jun, 2024 | 4 | |
20 Jun, 2024 | 4 | |
20 Jun, 2024 | 4 | |
20 Jun, 2024 | 4 | |
21 May, 2024 | 4 | |
21 May, 2024 | 4 | |
13 May, 2024 | SC 13G | |
13 May, 2024 | 8-K | |
9 May, 2024 | ARS | |
8 May, 2024 | SC 13D | |
8 May, 2024 | 8-K | |
8 May, 2024 | 10-Q | |
1 May, 2024 | 3 | |
30 Apr, 2024 | 8-K | |
29 Apr, 2024 | DEFA14A | |
29 Apr, 2024 | DEF 14A | |
22 Mar, 2024 | 10-K/A | |
7 Mar, 2024 | 4 | |
7 Mar, 2024 | 4 | |
7 Mar, 2024 | 4 | |
7 Mar, 2024 | 4 | |
5 Mar, 2024 | 10-K/A | |
4 Mar, 2024 | SC 13D/A | |
29 Feb, 2024 | 8-K | |
29 Feb, 2024 | 10-K | |
22 Feb, 2024 | 4 | |
22 Feb, 2024 | 4 | |
14 Feb, 2024 | SC 13G/A | |
13 Feb, 2024 | SC 13G/A | |
13 Feb, 2024 | SC 13G/A | |
9 Feb, 2024 | SC 13G | |
22 Jan, 2024 | 4 | |
22 Jan, 2024 | SC 13G/A | |
10 Jan, 2024 | 3 | |
22 Nov, 2023 | 4 | |
17 Nov, 2023 | 4 | |
13 Nov, 2023 | S-8 | |
6 Nov, 2023 | 8-K | |
1 Nov, 2023 | 10-Q | |
1 Nov, 2023 | 8-K | |
31 Aug, 2023 | 4 | |
31 Aug, 2023 | 4 | |
31 Aug, 2023 | 3 | |
25 Aug, 2023 | 8-K | |
7 Aug, 2023 | 8-K | |
2 Aug, 2023 | 4 | |
2 Aug, 2023 | 10-Q | |
2 Aug, 2023 | 3 | |
2 Aug, 2023 | 8-K | |
11 Jul, 2023 | SC 13D/A | |
11 Jul, 2023 | 8-K | CEO Change |
7 Jun, 2023 | 4 | |
30 May, 2023 | 4 | |
24 May, 2023 | 4 | |
24 May, 2023 | 8-K | |
24 May, 2023 | 8-K | |
24 May, 2023 | 4 | |
24 May, 2023 | 4 | |
24 May, 2023 | 4 | |
24 May, 2023 | 4 | |
24 May, 2023 | 4 | |
23 May, 2023 | 4 | |
19 May, 2023 | 4 | |
19 May, 2023 | 4/A | |
17 May, 2023 | DEFA14A | |
15 May, 2023 | 3 | |
15 May, 2023 | SC 13D/A | |
15 May, 2023 | 4 | |
9 May, 2023 | 10-Q | |
9 May, 2023 | 8-K | |
1 May, 2023 | DEFA14A | |
1 May, 2023 | 8-K | |
28 Apr, 2023 | DEF 14A | |
28 Apr, 2023 | ARS | |
17 Apr, 2023 | 4 | |
20 Mar, 2023 | 10-K/A | |
14 Mar, 2023 | 4 | |
28 Feb, 2023 | 10-K | |
28 Feb, 2023 | 8-K | |
22 Feb, 2023 | 4 | |
14 Feb, 2023 | SC 13G | |
13 Feb, 2023 | SC 13G/A | |
10 Feb, 2023 | SC 13G/A | |
9 Feb, 2023 | SC 13G/A | |
2 Feb, 2023 | SC 13G/A | |
26 Jan, 2023 | SC 13G/A | |
20 Jan, 2023 | SC 13G | |
12 Jan, 2023 | 4 | |
10 Jan, 2023 | SC 13D/A | |
6 Jan, 2023 | 3 | |
4 Jan, 2023 | 8-K | |
22 Nov, 2022 | 4 | |
9 Nov, 2022 | 8-K | |
9 Nov, 2022 | 10-Q | |
28 Oct, 2022 | 8-K/A | |
14 Sep, 2022 | 8-K | |
26 Aug, 2022 | 3 | |
23 Aug, 2022 | 8-K | |
22 Aug, 2022 | SC TO-T/A | |
22 Aug, 2022 | 4 | |
22 Aug, 2022 | 8-K | |
16 Aug, 2022 | SC TO-T/A | |
27 Jul, 2022 | 10-Q | |
27 Jul, 2022 | 8-K | |
25 Jul, 2022 | SC TO-T | |
20 Jul, 2022 | 8-K | |
13 Jul, 2022 | 8-K | |
13 Jul, 2022 | 4 | |
11 Jul, 2022 | 425 | |
11 Jul, 2022 | SC 13G/A | |
11 Jul, 2022 | SC 13D/A | |
11 Jul, 2022 | 8-K | |
11 Jul, 2022 | 8-K | |
11 Jul, 2022 | SC TO-C | |
8 Jul, 2022 | SC 13E3/A | |
8 Jul, 2022 | SC TO-T/A | |
17 Jun, 2022 | SC TO-T/A | |
17 Jun, 2022 | CORRESP | |
17 Jun, 2022 | SC 13E3/A | |
7 Jun, 2022 | SC TO-T | |
7 Jun, 2022 | SC 13E3 | |
24 May, 2022 | SC TO-C | |
24 May, 2022 | 8-K | |
24 May, 2022 | SC TO-C | |
24 May, 2022 | SC 13D/A | |
23 May, 2022 | 4 | |
5 May, 2022 | 10-Q | |
4 May, 2022 | 4 | |
4 May, 2022 | 8-K/A | |
2 May, 2022 | 8-K | |
29 Apr, 2022 | 8-K | |
28 Apr, 2022 | 8-K | |
27 Apr, 2022 | 4 | |
27 Apr, 2022 | 4 | |
27 Apr, 2022 | 4 | |
27 Apr, 2022 | 4 | |
27 Apr, 2022 | 4 | |
27 Apr, 2022 | 4 | |
7 Apr, 2022 | 8-K | |
1 Apr, 2022 | 8-K | |
1 Apr, 2022 | 4 | |
1 Apr, 2022 | SC 13D/A | |
25 Mar, 2022 | 8-K | |
25 Mar, 2022 | DEF 14A | |
21 Mar, 2022 | 8-K | |
17 Mar, 2022 | 10-K/A | |
15 Mar, 2022 | SC 13D/A | |
8 Mar, 2022 | 8-K | |
2 Mar, 2022 | 4 | |
28 Feb, 2022 | 10-K | |
23 Feb, 2022 | 4 | |
22 Feb, 2022 | 4 | |
22 Feb, 2022 | SC 13D/A | |
11 Feb, 2022 | 4 | |
11 Feb, 2022 | SC 13G/A | |
11 Feb, 2022 | SC 13D/A | |
10 Feb, 2022 | SC 13G/A | |
9 Feb, 2022 | 8-K | |
2 Feb, 2022 | SC 13D/A | |
1 Feb, 2022 | SC 13G | |
28 Jan, 2022 | SC 13G/A | |
13 Dec, 2021 | 8-K | |
22 Nov, 2021 | 4 | |
1 Nov, 2021 | 4 | |
1 Nov, 2021 | SC 13D/A | |
27 Oct, 2021 | 8-K | |
27 Oct, 2021 | 10-Q | |
24 Aug, 2021 | 4/A | |
23 Aug, 2021 | 4 | |
29 Jul, 2021 | 10-Q | |
28 Jul, 2021 | 8-K | |
14 Jun, 2021 | SC 13D/A | |
11 Jun, 2021 | 4 | |
7 Jun, 2021 | SC 13G/A | |
26 May, 2021 | 8-K | |
25 May, 2021 | 4 | |
25 May, 2021 | 4 | |
25 May, 2021 | SC 13D/A | |
25 May, 2021 | SC 13D/A | |
24 May, 2021 | 4 | |
24 May, 2021 | 4 | |
20 May, 2021 | 4 | |
20 May, 2021 | 4 | |
20 May, 2021 | 4 | |
20 May, 2021 | 4 | |
20 May, 2021 | 4 | |
20 May, 2021 | 4 | |
20 May, 2021 | 4 | |
20 May, 2021 | 8-K | |
20 May, 2021 | 8-K | |
5 May, 2021 | DEFA14A | |
3 May, 2021 | SC 13D/A | |
28 Apr, 2021 | 8-K | |
28 Apr, 2021 | 10-Q | |
5 Apr, 2021 | SC 13D/A | |
2 Apr, 2021 | DEF 14A | |
30 Mar, 2021 | 4 | |
30 Mar, 2021 | 4 | |
24 Mar, 2021 | 4 | |
17 Mar, 2021 | 4 | |
17 Mar, 2021 | SC 13D/A | |
16 Mar, 2021 | 3 | |
10 Mar, 2021 | 8-K | |
25 Feb, 2021 | 10-K | |
22 Feb, 2021 | 4 | |
12 Feb, 2021 | SC 13D/A | |
11 Feb, 2021 | SC 13G/A | |
10 Feb, 2021 | SC 13G/A | |
3 Feb, 2021 | 8-K | |
28 Jan, 2021 | 4 | |
27 Jan, 2021 | SC 13G/A | |
27 Jan, 2021 | SC 13D/A |
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.